{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:14:25Z","timestamp":1791231265098,"version":"4.1.0"},"reference-count":46,"publisher":"Scientific Foundation Spiroski (publications)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Access Maced J Med Sci"],"abstract":"<jats:p>BACKGROUND: Factor V Leiden, Prothrombin and MTHFR gene mutation, could have an influence in pregnancy with adverse outcome Preeclamsia, IUGR and Placental abruption.AIM: The aim of this study is to investigate the presence of above mentioned inherited thrombophilias and its statistical significance, distribution among the complicated and normal pregnancy, and relative risk for carrier of mutation to develop preeclampsia, IUGR and placental abruption.MATERIAL AND METHODS: Prospective cohort study is implemented at University Clinic for Obstetric and Gynecology in Skopje, Republic of Macedonia. The study included 109 delivered patients: 40 with preeclapmsia, 22 with IUGR, 17 with placental abruption and 30 as control group with normal pregnancy. The amount of 3 ml venous blood has been used for detection of these point mutations using ThromboStrip -Opegen, QIAGEN kit manufactured for thrombotic risk.RESULTS: The highest frequency was found: in the group with preeclampsia 35% were MTHFR homozygous, IUGR -MTHFR heterozygous 45%, Placental abruption- 52.9% MTHFR heterozygous, and in the control group without thrombophilia 56.7%. There were combined thrombophilia in 3 patients. There aren`t statistical significance in presence of thrombophilia among groups (p &gt; 0.05). Statistical significance (p &lt; 0.05) was found between carriers of MTHFR homozygous in preeclampsia and group with placental abruption and control group. Relative risk in IUGR group for MTHFR homozygous was 5.54 (1.37&lt;RR&lt;22.4). Relative risk in placental abruption for Factor V Leiden heterozygous was 4.50 (0.47&lt;RR&lt;42.75).CONCLUSION: The presence of mutation MTHFR homozygous could increase the risk for development of IUGR and mutation of Factor V Leiden for placental abruption. Further investigations with more patients are warranted.<\/jats:p>","DOI":"10.3889\/oamjms.2015.099","type":"journal-article","created":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T01:47:30Z","timestamp":1442627250000},"page":"590-594","source":"Crossref","is-referenced-by-count":14,"title":["Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption"],"prefix":"10.3889","volume":"3","author":[{"given":"Vesna","family":"Livrinova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Hadzi Lega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Hristova Dimcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Samardziski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozalinda","family":"Isjanovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"52292","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"13085","unstructured":"Calman R, et al. Basic Principle and Clinical Practice, 5th edition, Walter Kluwer, 2005."},{"key":"13086","doi-asserted-by":"crossref","unstructured":"Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344(16):1222-31.","DOI":"10.1056\/NEJM200104193441607"},{"key":"13087","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1056\/NEJM200104193441607","DOI":"10.1056\/NEJM200104193441607"},{"key":"13088","unstructured":"PMid:11309638"},{"key":"13089","unstructured":"Esman ET. The Dyoteinic anticoagulanth pathway \u00e2\u20ac\u201c Arterio Sclerosis. Thrombophilia. 1992;12:135."},{"key":"13090","doi-asserted-by":"crossref","unstructured":"Dahblack B. Resistance to activated C caused by the Factor V Mutation, common to risk factor for venous thrombosis. Thromb Haemost. 1997; 78: 438.","DOI":"10.1055\/s-0038-1657574"},{"key":"13091","doi-asserted-by":"crossref","unstructured":"Berhina RP et al. Associated mutation in coagulation factor V, associated with resistant to APC. Nature. 1994; 369: 64-67.","DOI":"10.1038\/369064a0"},{"key":"13092","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1038\/369064a0","DOI":"10.1038\/369064a0"},{"key":"13093","unstructured":"PMid:8164741"},{"key":"13094","unstructured":"Distefano et al. Screening for inherited thrombophilia.Indication and therapeutical implification. Haematologica. 2002; 87:1095-1108."},{"key":"13095","doi-asserted-by":"crossref","unstructured":"Franko RF, Reidsma Ph. Genetic Risk Factor of Venous Thrombosis. Human Genet. 2001; 109:369-84.","DOI":"10.1007\/s004390100593"},{"key":"13096","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1007\/s004390100593","DOI":"10.1007\/s004390100593"},{"key":"13097","unstructured":"PMid:11702218"},{"key":"13098","unstructured":"Arsov T, Miladinovic D, Spiroski M. Factor V Leiden is associated with Deep Venous Thrombosis of Large Blood vessel. Croat Med J. 2006; 47:433-439."},{"key":"13099","unstructured":"PMid:16758522 PMCid:PMC2080416"},{"key":"13100","unstructured":"Di Srefano, Rossi E et al. Screening for inherited thrombophilia: Indications and therapeutical implications. Haemathologica. 2002;87:1095-1108."},{"key":"13101","doi-asserted-by":"crossref","unstructured":"Gerhard A, et al. Prothrombin and Factor V Leiden mutation in women with history of thrombosis during pregnancy and puerperium. N Engl J Med. 2000; 342:374-380.","DOI":"10.1056\/NEJM200002103420602"},{"key":"13102","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1056\/NEJM200002103420602","DOI":"10.1056\/NEJM200002103420602"},{"key":"13103","unstructured":"PMid:10666427"},{"key":"13104","unstructured":"Martinelli P, Grandone E et al. Familial Thrombophilia and the occurrence of fetal growth restriction. Haemathologica. 2001;86:428-431."},{"key":"13105","unstructured":"Karegard M, Gennsen G. Incidence and recurrence rate of abruptio placentae in Sweden. Obstet Gynecol. 1996;175:902-905."},{"key":"13106","doi-asserted-by":"crossref","unstructured":"Kupferminc M, et al. Increased frequency of genetic thrombophilia in women with complication of pregnancy. N English Journal of Medicine. 1999;340:9-13.","DOI":"10.1056\/NEJM199901073400102"},{"key":"13107","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1056\/NEJM199901073400102","DOI":"10.1056\/NEJM199901073400102"},{"key":"13108","unstructured":"PMid:9878639"},{"key":"13109","doi-asserted-by":"crossref","unstructured":"Mello G, et al. Usefulness of screening for congenital or acquired haemostatic abnormalities in women with previous complicated pregnancy. Haemost. 1999;29:197\u00e2\u20ac\u201c203.","DOI":"10.1159\/000022502"},{"key":"13110","doi-asserted-by":"crossref","unstructured":"Many A, Schreiber et al. Pathological feature of the placenta in women with sever pregnancy complications and Trombophylia. Obstetrics and Gynecology .2001; 98: 1041-44.","DOI":"10.1097\/00006250-200112000-00010"},{"key":"13111","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1016\/S0029-7844(01)01621-0","DOI":"10.1016\/S0029-7844(01)01621-0"},{"key":"13112","doi-asserted-by":"crossref","unstructured":"Lindoff C et al. Preeclampsia is associated with reduce response to activated protein C. Am J Obstet Gynecol. 1997;176:457-460.","DOI":"10.1016\/S0002-9378(97)70515-5"},{"key":"13113","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1016\/S0002-9378(97)70515-5","DOI":"10.1016\/S0002-9378(97)70515-5"},{"key":"13114","doi-asserted-by":"crossref","unstructured":"D'Elia AV, Driul L, Giacomello R, Colaone R, Fabbro D, Di Leonardo C, Florio P, Petraglia F, Marchesoni D, Damante G. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol Obstet Invest. 2002;53(2):84-7.","DOI":"10.1159\/000052998"},{"key":"13115","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1159\/000052998","DOI":"10.1159\/000052998"},{"key":"13116","unstructured":"PMid:11961379"},{"key":"13117","unstructured":"Duchez F, Goffinet S, Degre P, Fournet. Thrombophilia and fetal growth restriction. Europian Journal of Ob and Gynecology. 2002; 36-40."},{"key":"13118","unstructured":"Dilley A. Thrombosis in pregnancy: The role of Factor V Leiden, protrombin gen and MTHFR in US population. Thromb Haemost. 1995;551-552."},{"key":"13119","unstructured":"Dordjevic V. Mutacija Faktor V Leiden, F II G 20210A i MTHTR C677T kod tromboza duboki vena u toku trudnoce sa praeklampsijama. Vojno Med Pregled. 2005; 3:201-205."},{"key":"13120","doi-asserted-by":"crossref","unstructured":"Infante-Rivard C, Rivard GE, Yotov WV et al. Association of thrombophilia polymorphism with intrauterine growth restriction. N Engl J Med. 2002;347:19-25.","DOI":"10.1056\/NEJM200207043470105"},{"key":"13121","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1056\/NEJM200207043470105","DOI":"10.1056\/NEJM200207043470105"},{"key":"13122","unstructured":"PMid:12097536"},{"key":"13123","unstructured":"Wiener-Megnasi Z, Ben Shlomo I, Shalev I. Resistance to activated protein C and Leiden mutation:High prevalence in women with sever pregnancy complication. Obst Gynecol. 2001; 97:753 \u00e2\u20ac\u201c 759."},{"key":"13124","doi-asserted-by":"crossref","unstructured":"Zootz RP, Gerthardt A. Inherited Thrombophilia and Gestational Venous Tromboembolism. Best Pract Res Clin Haematology. 2003;16:243-259.","DOI":"10.1016\/S1521-6926(03)00022-7"},{"key":"13125","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1016\/S1521-6926(03)00022-7","DOI":"10.1016\/S1521-6926(03)00022-7"},{"key":"13126","doi-asserted-by":"crossref","unstructured":"Grandone E, Margaglione M, Colaizzo D, et al. Gene succeptibility to pregnant related venous thrombembolism: Roles of factor V Leiden prothombin G20210A and MTHFR mutation. Am J Obstet Gynecology. 1998;179:1324-1328.","DOI":"10.1016\/S0002-9378(98)70155-3"},{"key":"13127","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1016\/S0002-9378(98)70155-3","DOI":"10.1016\/S0002-9378(98)70155-3"},{"key":"13128","doi-asserted-by":"crossref","unstructured":"Lin L, August P. Genetic Thrombophilias and preeclampsia: a meta analysis. Obstet Gynecol. 2003; 105:182-192.","DOI":"10.1097\/01.AOG.0000146250.85561.e9"},{"key":"13129","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1097\/01.AOG.0000146250.85561.e9","DOI":"10.1097\/01.AOG.0000146250.85561.e9"},{"key":"13130","unstructured":"PMid:15625161"}],"container-title":["Open Access Macedonian Journal of Medical Sciences"],"original-title":[],"link":[{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2015.099\/610","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2015.099\/527","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2015.099\/610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T13:40:22Z","timestamp":1624887622000},"score":1,"resource":{"primary":{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/view\/oamjms.2015.099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,12,15]]}},"URL":"https:\/\/doi.org\/10.3889\/oamjms.2015.099","relation":{},"ISSN":["1857-9655"],"issn-type":[{"value":"1857-9655","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]}}}